GNRH1 and posterior cortical atrophy: Thus, the primary objective of this study was to analyze real-world information on healthcare characteristics and treatment patterns in patients with locally advanced or metastatic PCa dependent on the prescribed GnRH agonist/antagonist agents (GnRHa) in the first 3 years after initiation.